[HTML][HTML] ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

A Dasari, VK Morris, CJ Allegra, C Atreya… - Nature reviews Clinical …, 2020 - nature.com
An increasing number of studies are describing potential uses of circulating tumour DNA
(ctDNA) in the care of patients with colorectal cancer. Owing to this rapidly developing area …

[HTML][HTML] The emerging role of ferroptosis in intestinal disease

S Xu, Y He, L Lin, P Chen, M Chen, S Zhang - Cell Death & Disease, 2021 - nature.com
Ferroptosis is a newly recognised type of regulated cell death (RCD) characterised by iron-
dependent accumulation of lipid peroxidation. It is significantly distinct from other RCDs at …

[HTML][HTML] Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline–Update 2022

P Pimentel-Nunes, D Libânio, BAJ Bastiaansen… - …, 2022 - thieme-connect.com
ESGE recommends that the evaluation of superficial gastrointestinal (GI) lesions should be
made by an experienced endoscopist, using high definition white-light and …

[HTML][HTML] Encorafenib plus cetuximab as a new standard of care for previously treated BRAF V600E–mutant metastatic colorectal cancer: updated survival results and …

J Tabernero, A Grothey, E Van Cutsem… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE BEACON CRC evaluated encorafenib plus cetuximab with or without binimetinib
versus investigators' choice of irinotecan or FOLFIRI plus cetuximab in patients with …

[HTML][HTML] Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline–update 2020

C Hassan, G Antonelli, JM Dumonceau, J Regula… - …, 2020 - thieme-connect.com
The following recommendations for post-polypectomy colonoscopic surveillance apply to all
patients who had one or more polyps that were completely removed during a high quality …

Colorectal cancer

E Dekker, PJ Tanis, JLA Vleugels, PM Kasi… - The Lancet, 2019 - thelancet.com
Several decades ago, colorectal cancer was infrequently diagnosed. Nowadays, it is the
world's fourth most deadly cancer with almost 900 000 deaths annually. Besides an ageing …

[HTML][HTML] The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: a systematic review and meta-analysis

GE Idos, J Kwok, N Bonthala, L Kysh, SB Gruber… - Scientific reports, 2020 - nature.com
Tumor-infiltrating lymphocytes (TILs) are an important histopathologic feature of colorectal
cancer that confer prognostic information. Previous clinical and epidemiologic studies have …

[HTML][HTML] Blockade of GCH1/BH4 axis activates ferritinophagy to mitigate the resistance of colorectal cancer to erastin-induced ferroptosis

Q Hu, W Wei, D Wu, F Huang, M Li, W Li… - Frontiers in cell and …, 2022 - frontiersin.org
Ferroptosis, a type of cell death triggered by excessive accumulation of iron-dependent lipid
peroxidation, possesses an excellent potential in cancer treatment. However, many …

[PDF][PDF] Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

SJ Wagner, D Reisenbüchler, NP West, JM Niehues… - Cancer Cell, 2023 - cell.com
Deep learning (DL) can accelerate the prediction of prognostic biomarkers from routine
pathology slides in colorectal cancer (CRC). However, current approaches rely on …

Regorafenib-avelumab combination in patients with microsatellite stable colorectal cancer (REGOMUNE): a single-arm, open-label, phase II trial

S Cousin, C Cantarel, JP Guegan, C Gomez-Roca… - Clinical Cancer …, 2021 - AACR
Purpose: Regorafenib is synergistic with immune checkpoint inhibition in colorectal cancer
preclinical models. Patients and Methods: This was a single-arm, multicentric phase II trial …